Table 3.
Correlations of PROFIT1 liver T1 with clinical and MRI characteristics of all patient cohorts combined and the Fontan cohort alone
| Variable | All patients |
Fontan patients |
||||
|---|---|---|---|---|---|---|
| Correlation coefficient | P value (2-tailed) | N | Correlation coefficient | P value (2-tailed) | N | |
| Age (mo) | 0.150 | 0.348 | 41 | 0.217 | 0.359 | 20 |
| Time since Fontan | 0.185 | 0.435 | 20 | |||
| Age at Fontan | −0.103 | 0.667 | 20 | |||
| EF of primary ventricle | −0.501 | 0.001 | 41 | 0.163 | 0.493 | 20 |
| SVEDVi | 0.355 | 0.023 | 41 | −0.041 | 0.863 | 20 |
| SVESVi | 0.425 | 0.006 | 41 | −0.053 | 0.826 | 20 |
| Mass index | 0.119 | 0.524 | 31 | 0.578 | 0.049 | 12 |
| Septum T1 | 0.346 | 0.036 | 37 | −0.148 | 0.559 | 18 |
| Lateral wall T1 | 0.241 | 0.157 | 36 | 0.324 | 0.205 | 17 |
| Liver T1 (MOLLI) | 0.869 | <0.001 | 37 | 0.515 | 0.029 | 18 |
EF, ejection fraction; MOLLI, modified Look-Locker inversion; MRI, magnetic resonance imaging; PROFIT1, proton density fat fraction with T2∗ imaging with water-specific T1; SVEDVi, systemic ventricle end diastolic volume indexed to BSA; SVESVi, systemic ventricle end systolic volume indexed to BSA.